against the NGF-receptor/TNF-receptor superfamily

Industry

CPC
C07K16/2878

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K16/00Immunoglobulins [IGs]

Current Industry

C07K16/2878against the NGF-receptor/TNF-receptor superfamily

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Synthetic immune receptors and methods of use thereof
- Patent number 12,269,859
- Issue date Apr 8, 2025
- Angeles Therapeutics, Inc.
- Preet M. Chaudhary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-human OX40 monoclonal antibody, preparation method t...
- Patent number 12,269,890
- Issue date Apr 8, 2025
- Nanjing GenScript Biotech Co., Ltd.
- Liusong Yin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Transthyretin immunoglobulin fusions
- Patent number 12,269,898
- Issue date Apr 8, 2025
- Amgen Inc.
- Kenneth Walker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonistic anti-tumor necrosis factor receptor 2 antibodies
- Patent number 12,269,891
- Issue date Apr 8, 2025
- The General Hospital Corporation
- Denise L. Faustman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptor comprising BCMA nanobody linked to a chim...
- Patent number 12,263,221
- Issue date Apr 1, 2025
- Neomics Pharmaceuticals LLC
- William A. Comrie
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 ant...
- Patent number 12,258,412
- Issue date Mar 25, 2025
- REGENERON PHARMACEUTICALS, INC.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cancer antigen targets and uses thereof
- Patent number 12,259,390
- Issue date Mar 25, 2025
- Memorial Sloan Kettering Cancer Center
- Michel Sadelain
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Modified Fc proteins comprising site-specific non-natural amino aci...
- Patent number 12,252,552
- Issue date Mar 18, 2025
- Sutro Biopharma, Inc.
- Christopher D. Thanos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD137 antibodies and method of treating colorectal cancer usin...
- Patent number 12,252,542
- Issue date Mar 18, 2025
- Shihuida Pharmaceutical Group (Jilin) Co., Ltd.
- Xin Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules that bind CD137 and OX40
- Patent number 12,252,537
- Issue date Mar 18, 2025
- invoX Pharma Limited
- Mihriban Tuna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-BCMA antibody and use thereof
- Patent number 12,252,541
- Issue date Mar 18, 2025
- ABL BIO INC.
- Kyungjin Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SIRPa antibodies and their therapeutic applications
- Patent number 12,252,546
- Issue date Mar 18, 2025
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Process for lyophilized pharmaceutical formulations of a therapeuti...
- Patent number 12,251,474
- Issue date Mar 18, 2025
- Amgen Inc.
- Clea Talley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CEACAM5-dependent 4-1BB-agonistic bispecific antibodies
- Patent number 12,247,081
- Issue date Mar 11, 2025
- LaNova Medicines Limited
- Runsheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-DR5 antibodies and methods of use thereof
- Patent number 12,247,080
- Issue date Mar 11, 2025
- GENMAB B.V.
- Marije Overdijk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies binding CTLA-4 and uses thereof
- Patent number 12,240,905
- Issue date Mar 4, 2025
- HARBOUR BIOMED (SHANGHAI) CO., LTD.
- Xin Gan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-HER2/anti-4-1BB bispecific antibody and use thereof
- Patent number 12,240,913
- Issue date Mar 4, 2025
- ABL Bio Inc.
- Hyejin Chung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies specific for OX40
- Patent number 12,240,911
- Issue date Mar 4, 2025
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Engraftment of stem cells with a combination of an agent that targe...
- Patent number 12,233,093
- Issue date Feb 25, 2025
- The Board of Trustees of the Leland Stanford Junior University
- Judith A. Shizuru
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bifunctional molecule and use thereof
- Patent number 12,234,479
- Issue date Feb 25, 2025
- CYTOCARES (SHANGHAI) INC.
- Shuai Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
FN14 antibodies and uses thereof
- Patent number 12,234,292
- Issue date Feb 25, 2025
- KYOWA KIRIN CO., LTD.
- Aihua Song
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment for primary amyloidosis with anti-BCMA binding protein
- Patent number 12,234,293
- Issue date Feb 25, 2025
- GlaxoSmithKline Intellectual Property Development Limited
- Sanjay Khandekar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition of a humanized anti-CD40 antibody
- Patent number 12,234,294
- Issue date Feb 25, 2025
- Kiniksa Pharmaceuticals, GmbH
- James Kranz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Continuous manufacturing process for bispecific antibody products
- Patent number 12,227,571
- Issue date Feb 18, 2025
- Amgen Inc.
- Chetan Goudar
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Anti-BCMA single domain antibodies and application thereof
- Patent number 12,227,581
- Issue date Feb 18, 2025
- SHENZHEN PREGENE BIOPHARMA CO., LTD.
- Jishuai Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-GDF15 antibodies, compositions and methods of use
- Patent number 12,227,564
- Issue date Feb 18, 2025
- Pfizer Inc.
- Kevin Charles Beaumont
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD137 agonist antibodies and uses thereof
- Patent number 12,227,582
- Issue date Feb 18, 2025
- QLSF BIOTHERAPEUTICS INC.
- Aaron Kurtzman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent and multispecific OX40-binding fusion proteins
- Patent number 12,227,584
- Issue date Feb 18, 2025
- Inhibrx Biosciences, Inc.
- Brendan P. Eckelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific 2+1 contorsbodies
- Patent number 12,227,594
- Issue date Feb 18, 2025
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-BCMA antibody drug conjugate combination treatment for cancer
- Patent number 12,227,585
- Issue date Feb 18, 2025
- GlaxoSmithKline Intellectual Property Development Limited
- Sanjay Khandekar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY TARGETING B CELL MATURATION ANTIGEN AND RELATED PRODUCTS T...
- Publication number 20250115674
- Publication date Apr 10, 2025
- Beijing Gene MiNK Biotechnology CO.LTD
- Zhihua Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AGONISTIC ANTIBODIES THAT BIND CD40
- Publication number 20250115663
- Publication date Apr 10, 2025
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Application of SIRT1-7 protein in immunotherapy
- Publication number 20250114400
- Publication date Apr 10, 2025
- Avenex Biosciences LTD.
- Youguo LING
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AGONIST FUSION PROTEIN FOR CD40 AND OX40 AND USES THEREOF
- Publication number 20250115673
- Publication date Apr 10, 2025
- Thomas Jefferson University
- Mark L. Tykocinski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOLATED NUCLEIC ACID MOLECULE COMPRISING NKP30 TRANSMEMBRANE DOMAI...
- Publication number 20250108114
- Publication date Apr 3, 2025
- PELL BIO-MED TECHNOLOGY CO., LTD.
- Felix HSU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF BCMAXCD3 BISP...
- Publication number 20250109211
- Publication date Apr 3, 2025
- JANSSEN BIOTECH, INC.
- Jenna Goldberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT FUSION PROTEIN TARGETING CD40 AND CD47
- Publication number 20250109212
- Publication date Apr 3, 2025
- BIOSION INC.
- Mingjiu CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF INFLAMMATORY DISORDERS
- Publication number 20250099754
- Publication date Mar 27, 2025
- SetPoint Medical Corporation
- Jacob A. LEVINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS FOR TREATING CANCER
- Publication number 20250099587
- Publication date Mar 27, 2025
- Kelonia Therapeutics, Inc.
- Kevin M. Friedman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTISPECIFIC BINDING MOLECULES COMPRISING LTBR AND EDB BINDING DOM...
- Publication number 20250101123
- Publication date Mar 27, 2025
- Cilag GMBH International
- Matthew LORENZI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS FOR TREATING CANCER
- Publication number 20250099615
- Publication date Mar 27, 2025
- Kelonia Therapeutics, Inc.
- Kevin M. Friedman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIGEN BINDING POLYPEPTIDES
- Publication number 20250101122
- Publication date Mar 27, 2025
- Kelonia Therapeutics, Inc.
- Kevin M. Friedman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BAFF-R TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T-CELLS AND USES...
- Publication number 20250092149
- Publication date Mar 20, 2025
- CITY OF HOPE
- Hong QIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEIN RECOVERY
- Publication number 20250092090
- Publication date Mar 20, 2025
- Bristol-Myers Squibb Company
- Abhiram Arunkumar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF A CELL THERAPY AND A GAMMA SECRETASE INHIBITOR
- Publication number 20250090542
- Publication date Mar 20, 2025
- Juno Therapeutics, Inc.
- Damian J. GREEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC POLYPEPTIDE CONSTRUCTS CONTAINING A CONSTRAINED CD3 B...
- Publication number 20250092137
- Publication date Mar 20, 2025
- Inhibrx Biosciences, Inc.
- Brendan P. ECKELMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NK/MONOCYTE ENGAGERS
- Publication number 20250084169
- Publication date Mar 13, 2025
- Biomolecular Holdings LLC
- Daniel J. Capon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONJUGATING REAGENTS AND CONJUGATES THEREOF
- Publication number 20250082768
- Publication date Mar 13, 2025
- Cambridge Enterprise Limited
- David Robert Spring
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENERATION OF CHIMERIC ANTIGEN RECEPTOR mRNA MOLECULES FOR EXPRESSI...
- Publication number 20250084175
- Publication date Mar 13, 2025
- ImmunityBio, Inc.
- Fereshteh PARVIZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FC BINDING FRAGMENTS COMPRISING A CD137 ANTIGEN-BINDING SITE
- Publication number 20250084176
- Publication date Mar 13, 2025
- invoX Pharma Limited
- Matthew Lakins
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20250074986
- Publication date Mar 6, 2025
- Medimmune, LLC
- SRINATH KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC CONSTRUCTS AND USES THEREOF
- Publication number 20250074995
- Publication date Mar 6, 2025
- I-Mab Biopharma Co., Ltd.
- Wenqing JIANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-GPRC5DxBCMAxCD3 TRISPECIFIC ANTIBODY AND USE THEREOF
- Publication number 20250074996
- Publication date Mar 6, 2025
- INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
- Wei XU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF
- Publication number 20250066482
- Publication date Feb 27, 2025
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-EGFR/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF
- Publication number 20250066487
- Publication date Feb 27, 2025
- ABL Bio Inc.
- Yeryoung Yong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-BCMA CAR T CELL COMPOSITIONS
- Publication number 20250064722
- Publication date Feb 27, 2025
- 2seventy bio, Inc.
- Travis Quigley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of dual-target CAR-T cells in treating B-cell autoimmune diseases
- Publication number 20250064855
- Publication date Feb 27, 2025
- GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD.
- Huan Shi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR TREATING MULTIPLE MYELOMA
- Publication number 20250064928
- Publication date Feb 27, 2025
- JANSSEN BIOTECH, INC.
- Rachel KOBOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-BCMA CAR T CELL COMPOSITIONS
- Publication number 20250064723
- Publication date Feb 27, 2025
- 2seventy bio, Inc.
- Travis Quigley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS
- Publication number 20250066473
- Publication date Feb 27, 2025
- The Board of Trustees of the Leland Stanford Junior University
- Stephen Willingham
- C07 - ORGANIC CHEMISTRY

against the NGF-receptor/TNF-receptor superfamily

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Synthetic immune receptors and methods of use thereof

Humanized anti-human OX40 monoclonal antibody, preparation method t...

Transthyretin immunoglobulin fusions

Agonistic anti-tumor necrosis factor receptor 2 antibodies

Chimeric antigen receptor comprising BCMA nanobody linked to a chim...

Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 ant...

Cancer antigen targets and uses thereof

Modified Fc proteins comprising site-specific non-natural amino aci...

Anti-CD137 antibodies and method of treating colorectal cancer usin...

Antibody molecules that bind CD137 and OX40

Anti-BCMA antibody and use thereof

Anti-SIRPa antibodies and their therapeutic applications

Process for lyophilized pharmaceutical formulations of a therapeuti...

CEACAM5-dependent 4-1BB-agonistic bispecific antibodies

Anti-DR5 antibodies and methods of use thereof

Antibodies binding CTLA-4 and uses thereof

Anti-HER2/anti-4-1BB bispecific antibody and use thereof

Bispecific antibodies specific for OX40

Engraftment of stem cells with a combination of an agent that targe...

Bifunctional molecule and use thereof

FN14 antibodies and uses thereof

Treatment for primary amyloidosis with anti-BCMA binding protein

Pharmaceutical composition of a humanized anti-CD40 antibody

Continuous manufacturing process for bispecific antibody products

Anti-BCMA single domain antibodies and application thereof

Anti-GDF15 antibodies, compositions and methods of use

CD137 agonist antibodies and uses thereof

Multivalent and multispecific OX40-binding fusion proteins

Bispecific 2+1 contorsbodies

Anti-BCMA antibody drug conjugate combination treatment for cancer

Patents Applicationslast 30 patents

ANTIBODY TARGETING B CELL MATURATION ANTIGEN AND RELATED PRODUCTS T...

AGONISTIC ANTIBODIES THAT BIND CD40

Application of SIRT1-7 protein in immunotherapy

AGONIST FUSION PROTEIN FOR CD40 AND OX40 AND USES THEREOF

ISOLATED NUCLEIC ACID MOLECULE COMPRISING NKP30 TRANSMEMBRANE DOMAI...

METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF BCMAXCD3 BISP...

RECOMBINANT FUSION PROTEIN TARGETING CD40 AND CD47

TREATMENT OF INFLAMMATORY DISORDERS

COMPOSITIONS FOR TREATING CANCER

MULTISPECIFIC BINDING MOLECULES COMPRISING LTBR AND EDB BINDING DOM...

COMPOSITIONS FOR TREATING CANCER

ANTIGEN BINDING POLYPEPTIDES

BAFF-R TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T-CELLS AND USES...

PROTEIN RECOVERY

COMBINATION OF A CELL THERAPY AND A GAMMA SECRETASE INHIBITOR

MULTISPECIFIC POLYPEPTIDE CONSTRUCTS CONTAINING A CONSTRAINED CD3 B...

NK/MONOCYTE ENGAGERS

CONJUGATING REAGENTS AND CONJUGATES THEREOF

GENERATION OF CHIMERIC ANTIGEN RECEPTOR mRNA MOLECULES FOR EXPRESSI...

FC BINDING FRAGMENTS COMPRISING A CD137 ANTIGEN-BINDING SITE

BISPECIFIC BINDING PROTEINS AND USES THEREOF

MULTISPECIFIC CONSTRUCTS AND USES THEREOF

ANTI-GPRC5DxBCMAxCD3 TRISPECIFIC ANTIBODY AND USE THEREOF

ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF

ANTI-EGFR/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF

ANTI-BCMA CAR T CELL COMPOSITIONS

Use of dual-target CAR-T cells in treating B-cell autoimmune diseases

METHODS FOR TREATING MULTIPLE MYELOMA

ANTI-BCMA CAR T CELL COMPOSITIONS

TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS